Clinical trial
A Prospective, Single-center, Investigator-blinded Trial to Evaluate the Safety and Efficacy of Secret Micro-Needle Fractional RF System® for the Treatment of Facial Wrinkles
NCT03426098 is registered in ClinicalTrials.gov with Goldman, Butterwick, Fitzpatrick and Groff as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Single-center, Investigator-blinded Trial to Evaluate the Safety and Efficacy of Secret Micro-Needle Fractional RF System® for the Treatment of Facial Wrinkles
- Lead sponsor
- Goldman, Butterwick, Fitzpatrick and Groff
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 10, 2018
- Completion date
- June 30, 2019
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aging, wrinkle